Used in pharmaceutical research as a key scaffold in the development of antidiabetic agents, particularly as a PPAR-γ agonist. Shows potential in modulating glucose metabolism and improving insulin sensitivity in preclinical studies. Also investigated for anti-inflammatory properties due to its structural similarity to known COX-2 inhibitors. Employed in structure-activity relationship (SAR) studies to optimize thiazolidinedione-based therapeutics. Serves as an intermediate in synthesizing novel heterocyclic compounds with biological activity.